Approval · Notice of Compliance 14063 · 2013
NAF PLUS: Notice of Compliance 14063
Issued February 11, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14063
- Date
- February 11, 2013
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Diagnostic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NAF PLUS | Not yet assigned | — |
Medicinal ingredients
- SODIUM FLUORIDE 18F 400 MCI per ML